These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8849331)

  • 1. Effects of anthralin and hypericin on growth factor signalling and cell proliferation in vitro.
    Richter A; Davies DE
    Biochem Pharmacol; 1995 Dec; 50(12):2039-45. PubMed ID: 8849331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro.
    Gottlieb AB; Khandke L; Krane JF; Staiano-Coico L; Ashinoff R; Krueger JG
    J Invest Dermatol; 1992 May; 98(5):680-5. PubMed ID: 1314863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.
    Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1211-20. PubMed ID: 12601051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
    Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin.
    de Witte P; Agostinis P; Van Lint J; Merlevede W; Vandenheede JR
    Biochem Pharmacol; 1993 Dec; 46(11):1929-36. PubMed ID: 8267642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
    Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
    Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of epidermal growth factor receptors by dithranol.
    Kemény L; Michel G; Arenberger P; Ruzicka T
    Acta Derm Venereol; 1993 Feb; 73(1):37-40. PubMed ID: 8095749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
    Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.
    Hwang MS; Yum YN; Joo JH; Kim S; Lee KK; Gee SW; Kang HI; Kim OH
    Anticancer Res; 2001; 21(4A):2649-55. PubMed ID: 11724334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor.
    Mothe I; Ballotti R; Tartare S; Kowalski-Chauvel A; Van Obberghen E
    Mol Biol Cell; 1993 Jul; 4(7):737-46. PubMed ID: 8400459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
    Modjtahedi H; Affleck K; Stubberfield C; Dean C
    Int J Oncol; 1998 Aug; 13(2):335-42. PubMed ID: 9664130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
    Bowen-Pope DF; Dicorleto PE; Ross R
    J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):57-62. PubMed ID: 8037691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.
    Jones HE; Dutkowski CM; Barrow D; Harper ME; Wakeling AE; Nicholson RI
    Int J Cancer; 1997 Jun; 71(6):1010-8. PubMed ID: 9185705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H; Chen JK
    J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785).
    Discafani CM; Carroll ML; Floyd MB; Hollander IJ; Husain Z; Johnson BD; Kitchen D; May MK; Malo MS; Minnick AA; Nilakantan R; Shen R; Wang YF; Wissner A; Greenberger LM
    Biochem Pharmacol; 1999 Apr; 57(8):917-25. PubMed ID: 10086326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin.
    Richter A; Davies DE; Alexander P
    Biochem Pharmacol; 1995 Jan; 49(3):367-73. PubMed ID: 7531976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin inhibits choroidal endothelial cell proliferation and cord formation in vitro.
    Kimura H; Harris MS; Sakamoto T; Gopalakrishna R; Gundimeda U; Cui JZ; Spee C; Hinton DR; Ryan SJ
    Curr Eye Res; 1997 Oct; 16(10):967-72. PubMed ID: 9330847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.